INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2019. The put-call ratio across all filers is 2.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,975,773 | +1.5% | 145,653 | +2.6% | 0.00% | 0.0% |
Q1 2024 | $9,825,778 | -9.1% | 141,991 | -5.9% | 0.00% | -33.3% |
Q4 2023 | $10,810,468 | +41.8% | 150,942 | +3.1% | 0.00% | 0.0% |
Q3 2023 | $7,624,516 | -16.5% | 146,372 | +1.5% | 0.00% | 0.0% |
Q2 2023 | $9,126,882 | +95.7% | 144,139 | +67.4% | 0.00% | +50.0% |
Q1 2023 | $4,663,777 | +9.3% | 86,127 | +6.8% | 0.00% | 0.0% |
Q4 2022 | $4,265,828 | +13.2% | 80,609 | -0.5% | 0.00% | +100.0% |
Q3 2022 | $3,770,000 | -21.1% | 81,029 | -3.2% | 0.00% | -50.0% |
Q2 2022 | $4,779,000 | +0.6% | 83,731 | +7.9% | 0.00% | +100.0% |
Q1 2022 | $4,750,000 | +37.0% | 77,627 | +17.2% | 0.00% | 0.0% |
Q4 2021 | $3,466,000 | +54.2% | 66,224 | +9.8% | 0.00% | 0.0% |
Q3 2021 | $2,248,000 | +17.7% | 60,295 | +28.8% | 0.00% | 0.0% |
Q2 2021 | $1,910,000 | +20.3% | 46,803 | +0.1% | 0.00% | 0.0% |
Q1 2021 | $1,588,000 | +23.7% | 46,774 | +15.9% | 0.00% | 0.0% |
Q4 2020 | $1,284,000 | +23.3% | 40,369 | -0.5% | 0.00% | – |
Q3 2020 | $1,041,000 | -3.2% | 40,555 | -3.2% | 0.00% | -100.0% |
Q2 2020 | $1,075,000 | +166.1% | 41,877 | +59.3% | 0.00% | – |
Q1 2020 | $404,000 | -44.3% | 26,285 | +24.5% | 0.00% | – |
Q4 2019 | $725,000 | +433.1% | 21,107 | +15.9% | 0.00% | – |
Q3 2019 | $136,000 | -34.9% | 18,215 | +13.5% | 0.00% | – |
Q2 2019 | $209,000 | +6.6% | 16,044 | 0.0% | 0.00% | – |
Q1 2019 | $196,000 | +7.1% | 16,044 | 0.0% | 0.00% | – |
Q4 2018 | $183,000 | -42.6% | 16,044 | +9.4% | 0.00% | – |
Q3 2018 | $319,000 | +23.2% | 14,670 | 0.0% | 0.00% | – |
Q2 2018 | $259,000 | -20.8% | 14,670 | -5.5% | 0.00% | – |
Q1 2018 | $327,000 | +20.7% | 15,532 | -16.4% | 0.00% | – |
Q4 2017 | $271,000 | +1.9% | 18,590 | +9.7% | 0.00% | – |
Q3 2017 | $266,000 | +160.8% | 16,942 | +105.7% | 0.00% | – |
Q2 2017 | $102,000 | -23.9% | 8,235 | 0.0% | 0.00% | – |
Q1 2017 | $134,000 | +5.5% | 8,235 | -1.4% | 0.00% | – |
Q4 2016 | $127,000 | +98.4% | 8,350 | +89.9% | 0.00% | – |
Q3 2016 | $64,000 | -67.7% | 4,398 | -16.7% | 0.00% | – |
Q2 2016 | $198,000 | +76.8% | 5,282 | +29.3% | 0.00% | – |
Q1 2016 | $112,000 | -38.1% | 4,085 | +22.2% | 0.00% | – |
Q4 2015 | $181,000 | +42.5% | 3,343 | 0.0% | 0.00% | – |
Q3 2015 | $127,000 | +23.3% | 3,343 | 0.0% | 0.00% | – |
Q2 2015 | $103,000 | +25.6% | 3,343 | 0.0% | 0.00% | – |
Q1 2015 | $82,000 | +36.7% | 3,343 | 0.0% | 0.00% | – |
Q4 2014 | $60,000 | +25.0% | 3,343 | 0.0% | 0.00% | – |
Q3 2014 | $48,000 | – | 3,343 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |